Femtosecond laser-assisted surgery for cataract patients with shallow anterior chambers benefits both patients and surgeons, a new trial suggests. Medscape Medical News
Category: News
Learning to Love Electronic Medical Records
Fighting through autofill errors and drop-down menu frustrations, an optometrist keeps an optimistic outlook on the future of electronic medical records. Medscape Optometry
CareCredit and Visionworks Expand Exclusive Patient Financing Agreement
COSTA MESA, Calif. & SAN ANTONIO–(BUSINESS WIRE)–CareCredit and Visionworks expand exclusive patient financing agreement to include all Visionworks locations.
Europe Cataract Treatment Market Report 2016-2020 – Analysis, Technologies & Forecasts – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Europe Cataract Treatment Market and Competitive Landscape Highlights – 2016” report to their offering. The research focuses on key countries such as Germany, France, Ital…
Hoya Reports Fourth Quarter Results; Achieves Record Annual Sales and Profit
TOKYO–(BUSINESS WIRE)–HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2016. During the quarter, revenues decreased by 4.5% to 121,666 million yen year on year. Pre-tax profit for th…
Acucela Initiates Phase 2 Clinical Trial Addressing Proliferative Diabetic Retinopathy
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, announced today that the company initiated a phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT02753400) with the successful enrollment of the first patient, to assess the benefits of emixustat hydrochloride (emixustat) for the treatment of pro
Stents Reduce Need for Open-Angle Glaucoma Meds
A meta-analysis looking at the addition of trabecular stent implantation to phacoemulsification assessed efficacy and safety, and whether two stents are better than one. Medscape Medical News
D.C. Week: CMS Open to Changes in Part B Proposal
(MedPage Today) — Also, FDA advisors give mixed review to novel opioid painkiller
Serum biomarkers can help predict risk of IBD development and complications
Years before inflammatory bowel disease (IBD) is diagnosed and symptoms exist, biomarkers are already circulating that can help predict risk not only of disease development but also of complications, according to research published online last week, which will also appear in the June 15th print issue of Alimentary Pharmacology & Therapeutics.
Specs-Mounted Camera ‘Could Aid Poor Vision’
A tiny camera which can translate text into speech could help improve the lives of people with poor vision, researchers say. WebMD Health News
New eye scan may detect onset of Alzheimer’s disease
Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer’s disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.
Glaucoma drug-dispensing eye insert shows promise as new option for patients struggling to take daily prescription eye drops
Silicone ring that rests on the eye releases medication slowly over six months, could help lower risk of vision loss among seniors with the disease.
Device worn on eyeglasses offers hope for people with low vision
A miniature camera using optical character-recognition technology, mounted onto the eyeglasses of people who are considered legally blind, dramatically improves their ability to read an email…
Leica Microsystems launches IOLcompass Pro intraocular lens positioning system
Leica Microsystems in partnership with TrueVision Systems Inc. launches the IOLcompass Pro. IOLcompass Pro is a software-based guidance system for pre-operative planning and intra-operative positioning of premium intraocular lenses (IOLs). It supports …
Lumenis to Present Interim Safety and Efficacy Results of IPL with OPT™ for Treating Dry Eye at Major Ophthalmology Meeting
YOKNEAM, Israel–(BUSINESS WIRE)–ASCRS Booth #2311– Lumenis, Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, will present interim results of a multicenter prospective clinical trial designed to study the safety and efficacy of Optimal Pulse Technology (OPTTM), the next generation of Intense Pulse Light (IPL) technology, for treating Dry Eye Disease (DED). Data from the trial, being led by Steven J. Dell, MD, of Dell Laser Cons
Portable artificial vision device may be an effective aid for patients with low vision
In a small study that included 12 legally blind participants, use of a portable artificial vision device improved the patient’s ability to perform tasks simulating those of daily living, such as…
RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research in Upcoming Conferences
ANN ARBOR, Mich.–(BUSINESS WIRE)–CEO Sean Ainsworth will highlight RetroSense’s contributions to gene therapy research during panel presentations at the NY BIO 2016 Annual Meeting and the Piper Jaffray GenomeRx Symposium.
Global Glaucoma Market 2016 – Valuations, Analysis & Forecast – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Glaucoma Market and Competitive Landscape Highlights – 2016” report to their offering. The latest research report provides comprehensive insights into pipeline prod…
Morning Break: Easy Dementia Screen; Real Surgical Robot
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff
Blueberry component PS may protect against dry eye disease
Pterostilbene (PS), a component of blueberries, have been found to protect against dry eye disease according to a new study.